Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives
Shayna Sarosiek, Vaishali Sanchorawala Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USACorrespondence: Shayna Sarosiek; Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and Boston Medical Center, 820 Harrison Ave, FGH Bu...
Main Authors: | Sarosiek S, Sanchorawala V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-options-for-relapsedrefractory-systemic-light-chain-al-amylo-peer-reviewed-article-JBM |
Similar Items
-
Retinitis pigmentosa associated with systemic light chain amyloidosis (AL amyloidosis)
by: Salem Bouomrani, et al.
Published: (2021-04-01) -
How I manage systemic light chain amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-09-01) -
The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis
by: The Inaugural Amyloidosis Forum Panelists, et al.
Published: (2020-09-01) -
Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression
by: Yong Hwan Ahn, et al.
Published: (2018-05-01) -
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
by: Giuseppe Vergaro, MD, PhD, et al.
Published: (2021-03-01)